InvestorsHub Logo
Followers 74
Posts 3281
Boards Moderated 0
Alias Born 03/16/2014

Re: None

Friday, 11/06/2020 5:56:19 AM

Friday, November 06, 2020 5:56:19 AM

Post# of 716329
Larry Smith :

These posts don’t offer any insight into what the FDA might do. However, it is very difficult for me to believe that they would not agree with regulatory agencies in Europe on the appropriateness of using mOS as an endpoint. However, it is not impossible.



WE NEED THE US ENDPOINTS CHANGED FOR TWO REASONS, FIRST TO MAKE THE SHARE PRICE GO UP ( COME ON LETS BE HONEST ) AND SECONDLY TO AVOID UTTER CONFUSION WHEN TLD IS PR'd

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent NWBO News